Benjamin R Poh1, Paul A Cashin1,2, Daniel G Croagh3,4. 1. Upper GI/HPB Surgery Unit, Monash Health, 246 Clayton Rd, Clayton, VIC, 3168, Australia. 2. Department of Surgery, School of Clinical Sciences, Monash Health, Monash University, Melbourne, VIC, Australia. 3. Upper GI/HPB Surgery Unit, Monash Health, 246 Clayton Rd, Clayton, VIC, 3168, Australia. daniel.croagh@monashhealth.org. 4. Department of Surgery, School of Clinical Sciences, Monash Health, Monash University, Melbourne, VIC, Australia. daniel.croagh@monashhealth.org.
Abstract
INTRODUCTION: Traditional teaching dictates that it may not be prudent to take the jaundiced patient to theatre for emergency laparoscopic cholecystectomy as they may experience worse outcomes following surgery. METHODS: A prospective cohort of 104 patients undergoingemergency laparoscopic cholecystectomy was stratified into two groups using a serum total bilirubin of above 50 μmol/L (2.9 mg/dL) to define the jaundiced group. Primary outcomes were morbidity and mortality rate. The Clavien-Dindo classification and the novel Comprehensive Complication Index (CCI) were applied to the grading of surgical complications. Multivariate analysis to identify possible predictors of morbidity and length of stay was also performed. RESULTS:Overall morbidity rate in the jaundiced group was 28 versus 36% (control), p = 0.405. Mean CCI in the jaundiced group was 5.28 versus 8.00 in the control group, p = 0.229. Mean length of stay was shorter in the jaundiced group, 4.65 versus 6.51 days, p = 0.036. There were no peri-operative mortalities or conversions to open surgery. Only male gender and the presence of retained stones were found to be associated with morbidity. Serum total bilirubin was not associated with increased morbidity. CONCLUSION: Amongst patients undergoinglaparoscopic cholecystectomy who are found to have choledocholithiasis on IOC, the presence of jaundice does not appear to contribute towards increased morbidity.
RCT Entities:
INTRODUCTION: Traditional teaching dictates that it may not be prudent to take the jaundicedpatient to theatre for emergency laparoscopic cholecystectomy as they may experience worse outcomes following surgery. METHODS: A prospective cohort of 104 patients undergoing emergency laparoscopic cholecystectomy was stratified into two groups using a serum total bilirubin of above 50 μmol/L (2.9 mg/dL) to define the jaundiced group. Primary outcomes were morbidity and mortality rate. The Clavien-Dindo classification and the novel Comprehensive Complication Index (CCI) were applied to the grading of surgical complications. Multivariate analysis to identify possible predictors of morbidity and length of stay was also performed. RESULTS: Overall morbidity rate in the jaundiced group was 28 versus 36% (control), p = 0.405. Mean CCI in the jaundiced group was 5.28 versus 8.00 in the control group, p = 0.229. Mean length of stay was shorter in the jaundiced group, 4.65 versus 6.51 days, p = 0.036. There were no peri-operative mortalities or conversions to open surgery. Only male gender and the presence of retained stones were found to be associated with morbidity. Serum total bilirubin was not associated with increased morbidity. CONCLUSION: Amongst patients undergoing laparoscopic cholecystectomy who are found to have choledocholithiasis on IOC, the presence of jaundice does not appear to contribute towards increased morbidity.
Authors: John T Maple; Tamir Ben-Menachem; Michelle A Anderson; Vasundhara Appalaneni; Subhas Banerjee; Brooks D Cash; Laurel Fisher; M Edwyn Harrison; Robert D Fanelli; Norio Fukami; Steven O Ikenberry; Rajeev Jain; Khalid Khan; Mary Lee Krinsky; Laura Strohmeyer; Jason A Dominitz Journal: Gastrointest Endosc Date: 2010-01 Impact factor: 9.427
Authors: Ksenija Slankamenac; Nina Nederlof; Patrick Pessaux; Jeroen de Jonge; Bas P L Wijnhoven; Stefan Breitenstein; Christian E Oberkofler; Rolf Graf; Milo A Puhan; Pierre-Alain Clavien Journal: Ann Surg Date: 2014-11 Impact factor: 12.969
Authors: Kohji Okamoto; Tadahiro Takada; Steven M Strasberg; Joseph S Solomkin; Henry A Pitt; O James Garden; Markus W Büchler; Masahiro Yoshida; Fumihiko Miura; Yasutoshi Kimura; Ryota Higuchi; Yuichi Yamashita; Toshihiko Mayumi; Harumi Gomi; Shinya Kusachi; Seiki Kiriyama; Masamichi Yokoe; Wan-Yee Lau; Myung-Hwan Kim Journal: J Hepatobiliary Pancreat Sci Date: 2013-01 Impact factor: 7.027